PaxMedica, Inc. Common Stock
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intra…
Biotechnology
US, Tarrytown [HQ]
Resulting Ratios
5 Records · Starting from 2019
Loading...